|
|
Recognizing the limitations of this retrospective study,it appears nonetheless that conventional stroke origins account for the majority of cerebral ischemic events in the adult cancer population.Although hypercoagulability is present to a greater extent than in the nononcological population,recurrent strokes seem to occur no more frequently than in the nononcological population,and antiplatelet agents seem sufficient therapy for most patients. |
|